the personalization of neoadjuvant immunotherapy in stage iii melanoma
Published 1 year ago • 259 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
2:33
opacin-neo & prado 3-year results in stage iii melanoma: personalized neoadjuvant io benefits
-
1:20
neopele: neoadjuvant pembrolizumab and lenvatinib in resectable stage iii melanoma
-
3:09
advances in utilizing neoadjuvant immunotherapy in melanoma
-
2:24
prado: personalized response-driven therapy in resectable stage iii melanoma
-
4:02
prado: personalized response-driven surgery and adjuvant therapy in stage iii melanoma
-
1:55
neoadjuvant ipilimumab plus nivolumab in stage iii melanoma
-
0:40
gamma signature guidance in optimizing neoadjuvant immunotherapy for resectable melanoma
-
1:54
opacin-neo and prado: personalized neoadjuvant io for melanoma based on pathologic response
-
0:35
potential advantages of neoadjuvant immunotherapy for melanoma
-
1:55
impact of emotional distress on pathologic response in high-risk stage iii melanoma
-
5:18
neoadjuvant ipilimumab and nivolumab immunotherapy for resectable stage iii melanoma
-
1:39
opacin and opacin-neo: neoadjuvant immunotherapy for advanced melanoma
-
2:22
#esmo22 highlights on neoadj. vs adjuvant pembrolizumab in resected stage iii-iv melanoma:swog s1801
-
1:00
dr. blank on personalizing neoadjuvant therapy in stage iii macroscopic melanoma
-
1:40
swog s1801: benefits of neoadjuvant immunotherapy for patients with resectable melanoma
-
3:44
neoadjuvant approaches in melanoma
-
1:09
clinical implications of neoadjuvant immunotherapy in cscc
-
2:12
omitting total lymph node dissection and adjuvant therapy in melanoma
-
4:27
key updates in immunotherapies for melanoma